Home » Authors » Anette Breindl

Articles by Anette Breindl

New Research Seeks To Provide Solace For Chronic Pain Patients

Oct. 27, 2006

By Anette Breindl

New Research Seeks To Provide Solace For Chronic Pain Patients

Oct. 27, 2006

By Anette Breindl

Activity Pattern Is More Affected Than Firing Level In Parkinson's

Oct. 25, 2006

By Anette Breindl

Activity Pattern Is More Affected Than Firing Level In Parkinson's

Oct. 25, 2006

By Anette Breindl

Enzyme Inhibitor Goes Past Diabetes To Sepsis, Cancer

Oct. 20, 2006

By Anette Breindl

Enzyme Inhibitor Goes Past Diabetes To Sepsis, Cancer

Oct. 20, 2006

By Anette Breindl

Peptide Anti-Infectives Increase Reach While Contracting Length

Oct. 19, 2006

By Anette Breindl

Peptide Anti-Infectives Increase Reach While Contracting Length

Oct. 19, 2006

By Anette Breindl

Unbiased Cell Cycle Work Reveals Surprise Players

Oct. 16, 2006

By Anette Breindl

Unbiased Cell Cycle Work Reveals Surprise Players

Oct. 16, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...